The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.

PLoS One · 2019 · PMC6319811 · PMID 30608986

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

could be considered significantno p-value reported

Conclusions Lyme disease imposes an economic burden that could be considered significant in the US and other developed countries to justify further research efforts in disease control and management.

also in 229 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.